scPharmaceuticals Inc.

NasdaqGS:SCPH Stock Report

Market Cap: US$218.6m

scPharmaceuticals Balance Sheet Health

Financial Health criteria checks 4/6

scPharmaceuticals has a total shareholder equity of $9.3M and total debt of $40.0M, which brings its debt-to-equity ratio to 432.3%. Its total assets and total liabilities are $65.5M and $56.2M respectively.

Key information

432.3%

Debt to equity ratio

US$39.99m

Debt

Interest coverage ration/a
CashUS$38.88m
EquityUS$9.25m
Total liabilitiesUS$56.21m
Total assetsUS$65.46m

Recent financial health updates

Recent updates

Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?

Jun 27
Is scPharmaceuticals (NASDAQ:SCPH) Using Too Much Debt?

scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable

Jun 27
scPharmaceuticals Inc. (NASDAQ:SCPH) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable

The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts

Mar 16
The scPharmaceuticals Inc. (NASDAQ:SCPH) Full-Year Results Are Out And Analysts Have Published New Forecasts

Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?

Nov 25
Is scPharmaceuticals (NASDAQ:SCPH) Using Debt Sensibly?

scPharmaceuticals: Furoscix Approval A Potential Paradigm Shift For Heart Failure Patients

Oct 20

FDA approves scPharmaceuticals Furoscix to treat congestion in heart failure

Oct 10

Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?

Jan 11
Does scPharmaceuticals (NASDAQ:SCPH) Have A Healthy Balance Sheet?

Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?

Sep 02
Is scPharmaceuticals (NASDAQ:SCPH) A Risky Investment?

scPharmaceuticals: We Still See A High Probability Of Success For FUROSCIX

Aug 26

Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like

Mar 09
Here's What scPharmaceuticals Inc.'s (NASDAQ:SCPH) Shareholder Ownership Structure Looks Like

How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?

Nov 24
How Many scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Do Institutions Own?

Financial Position Analysis

Short Term Liabilities: SCPH's short term assets ($62.6M) exceed its short term liabilities ($12.9M).

Long Term Liabilities: SCPH's short term assets ($62.6M) exceed its long term liabilities ($43.3M).


Debt to Equity History and Analysis

Debt Level: SCPH's net debt to equity ratio (12%) is considered satisfactory.

Reducing Debt: SCPH's debt to equity ratio has increased from 15.3% to 432.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SCPH has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: Insufficient data to determine if SCPH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies